Company Description
REXN (NASDAQ: rexn) is a publicly traded biotechnology company in the Health Technology sector.
rexn stock has declined 11.7% over the past year.
This page provides a comprehensive overview of rexn stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-11.71%
Performance 1 year
$0.0
REXN (rexn) stock. Over the past 12 months, the stock has lost 11.7%.
Latest News
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
rexn Company Profile & Sector Positioning
REXN (rexn) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.